HIGHLIGHTS
-
•
The prevalence of H. pylori in our study was 32.9%.
-
•
Most of the dyspeptic patients were found to have gastritis endoscopically.
-
•
The presence of H. pylori infection was found in 55.5% of duodenal ulcer cases.
Keywords: PCR, Polymerase Chain Reaction
KEYWORDS: Helicobacter pylori, dyspepsia, endoscopy, histopathology, ureC gene PCR
Abstract
Objectives
Conventional upper-intestinal endoscopy is usually performed to diagnose Helicobacter pylori (H. pylori) associated diseases, using gastric mucosa from the biopsy. The objective of our study was to identify the prevalence of H. pylori and its relation with endoscopic findings and histopathological features in dyspeptic adult patients.
Methods
Gastroduodenal biopsy specimens were collected from 143 adult dyspeptic outpatients who attended the Department of Gastroenterology, Bangabandhu Sheikh Mujib Medical University (BSMMU) and Dhaka Medical College Hospital (DMCH), for endoscopy. H. pylori was identified by rapid urease test (RUT), ureC gene PCR, and histological staining (Giemsa).
Results
The study population was divided into H. pylori-positive cases (47; 32.9%) and H. pylori-negative cases (96; 67.1%), based on the case definitions used in the study. The highest rate of H. pylori infection was found in the 41–50 years age group (25.5%). Endoscopically, 101 (97.1%) dyspeptic patients had gastritis, with the majority of H. pylori infections found among histopathologically diagnosed duodenal ulcer patients. Endoscopic findings were significantly correlated with histological findings (p < 0.001).
Conclusion
Significant correlations between endoscopic and histopathological findings were observed. Early detection and prompt treatment of H. pylori infection are essential for the prevention of serious complications.
Introduction
Dyspepsia is a term used for acute, chronic, or recurrent pain or discomfort centered in the upper abdomen. It may be associated with upper abdominal fullness, early satiety, bloating, burning, belching, nausea, retching, and vomiting (Conroy and Siddiqi, 2007). In the western world, the prevalence of dyspepsia has been reported as ranging from 25% to 50% (Niknam et al., 2014), while in Asia 8–30% of people suffer from dyspepsia (Ghoshal et al., 2011). Dyspeptic individuals are over two times more likely to be Helicobacter pylori (H. pylori)-positive than asymptomatic individuals (Aminde et al., 2019). As many as 80% of developing country residents carry H. pylori in their gastric mucosa, but only around 10-20% of infected individuals become symptomatic (Klusters et al., 2006). The most common symptom of H. pylori infection is dyspepsia, which is considered one of the most common causes of patient referrals to gastroenterology centers (Mapel et al., 2013). The prevalence of H. pylori infection in adult dyspeptic patients in India has been reported as 32.9% (Srinivas et al., 2016). A Bangladeshi study reported a prevalence of 47.8% H. pylori-positive cases among dyspeptic adult patients (Saha et al., 2018).
H. pylori has been linked to gastritis, duodenal ulcer, gastric carcinoma, and mucosa-associated lymphoid malignancies (Mishra et al., 2008). It is classified as a class 1 carcinogen by the World Health Organization (WHO) and the International Agency for Research on Cancer (Smith et al., 2014). Treatment for H. pylori infection is recommended in all symptomatic individuals in order to prevent the development of gastric adenocarcinoma and for the successful treatment of H. pylori-induced mucosa-associated lymphoid tissue (MALT) lymphoma (Fock et al., 2009).
Several invasive and noninvasive techniques are currently used for detecting H. pylori infection, including rapid urease test (RUT), urea breath test, culture, PCR, serological tests, and histopathological methods (Krogfelt et al., 2005). Each test has its benefits and limitations in different clinical situations. None of these diagnostic tools is considered to be the gold standard, due to poor sensitivity or specificity. Conventional endoscopy, however, is a powerful diagnostic tool for diseases of the upper gastrointestinal tract, as it is necessary to view the condition of the mucosal lining of the stomach and duodenum (Nguyen et al., 2010). Moreover, gastric biopsy samples obtained during endoscopy are the best specimens for the isolation of H. pylori (Mégraud and Lehours, 2007). The choice of diagnostic test depends on the prevalence of H. pylori, the incidence of age-related gastric cancer in the area, the accessibility, advantages, and disadvantages of each method, and the different clinical circumstances for each patient (Selgrad and Malfertheiner, 2017).
This study was conducted to assess the relationship between upper GIT endoscopic findings associated with several gastroduodenal diseases and the presence of H. pylori infection among dyspeptic patients in Dhaka, Bangladesh.
Materials and Methods
This study included 143 adult Bangladeshi outpatients who underwent upper gastrointestinal endoscopic examination for various dyspeptic symptoms, including abdominal pain, nausea, vomiting, belching, lower chest pain, upper gastrointestinal bleeding, and weight loss, in the Department of Gastroenterology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, and Dhaka Medical College Hospital, Dhaka. This cross-sectional observational study was conducted over a period of 12 months, beginning in March 2018, in the Department of Microbiology and Immunology, Bangabandhu Sheikh Mujib Medical University (BSMMU).
Patients with severe medical illness and a history of intake of proton pump inhibitors, non-steroidal anti-inflammatory drugs (NSAID), colloidal bismuth compounds, or antibiotics for eradication of H. pylori over 4 weeks prior to enrolment were excluded from the study (Tongtawee et al., 2016). Once written informed consent had been collected from each patient, gastric tissues were collected from lesions and sites surrounding the gastric antrum and body. Biopsy samples were obtained using a standard forward-viewing video fiberoptic endoscope (Olympus EVIS EXERA III, CV-190, USA) with the patients in a left-lateral position, under topical lignocaine (2%) anesthesia. To avoid contamination, the endoscope was carefully cleaned and disinfected before and after each procedure. The first biopsy specimen was inoculated immediately into a screw-capped bottle containing rapid urease test (RUT) media; a positive result was indicated by a change in color from yellow to pink within 24 hours after incubation at 37°C. The next specimen was fixed in 10% buffered formalin and transported to the Department of Pathology, BSMMU for histological examination. Another biopsy specimen was collected in PBS for PCR, and stored at −20°C until DNA extraction was performed.
Histological examination
Tissue sections were prepared and stained with hematoxylin and eosin (H&E) for the diagnosis of gastroduodenal diseases and modified Giemsa stain for H. pylori detection. Based on histological examination findings, the study subjects were diagnosed as either chronic gastritis, chronic gastric ulcer, duodenal ulcer, intestinal metaplasia, or gastric carcinoma.
ureC gene PCR
DNA was extracted from gastric tissues using QIAmp DNA mini kits (Qiagen, Hilden, Germany), according to the manufacturer's instructions. The ureC primer sequences used were: ureC-F 5′-AAGCTTTTAGGGGTGTTAGGGGTTT-3′, and ureC-R 5′-AAGCTTACTTTCTAACACTAACGC-3′. Amplification was performed according to Lu et al. (1999). The ureC gene PCR amplification products were 294 base pairs, and were electrophoresised in 2% agarose gel at 110 V for 42 minutes.
The study populations were categorized into two groups based on the case definitions used for this study. Patients were considered as H. pylori-positive when positive results were obtained in at least two of the three testing methods (rapid urease test, histology for H. pylori, and PCR for the ureC gene)
Data analysis
Descriptive and frequency analyses of the data from the study were expressed as counts, percentages, and means or medians, as appropriate, to provide an overall picture. The data were analyzed using the Statistical Package for Social Sciences (SPSS) version 23 (IBM, Armonk, New York). A chi-square/exact test was used where applicable. P-values < 0.05 were considered as denoting statistical significance.
Results
In total, 143 gastric biopsy specimens were collected from outpatients with dyspeptic symptoms who underwent endoscopy in the Department of Gastroenterology, BSMMU and Dhaka Medical College Hospital. RUT, histopathological examination, and PCR amplification of ureC gene for detection of H. pylori were performed.
The study populations were categorized into two groups according to the case definitions used in this study: H. pylori-positive patients (n = 47) and H. pylori-negative patients (n = 96) (Table 1).
Table 1.
Distribution of study population according to case definition (n = 143)
Study population | Number of cases | Percentage (%) |
---|---|---|
H. pylori-positive cases | 47 | 32.9 |
H. pylori-negative cases | 96 | 67.1 |
Of the 47 H. pylori-positive cases, 91.5% were found to be positive by rapid urease test, followed by ureC gene PCR (89.3%), and histological staining (74.4%).
Of all 143 patients, 71 (49.7%) were female and 72 (50.3%) were male, giving an almost equal male:female ratio of 1.00:1.01). Of the 47 (32.9%) patients infected with H. pylori, 22 (46.8%) were male and 25 (53.2%) were female; thus, infection did not differ significantly between males and females (p = 0.553). Age and sex data for the patient cohort are shown in Table 2.
Table 2.
Age and sex distribution of study population
Characteristics | All patients (n = 143) |
H. pylori (+) (n = 47) |
H. pylori (−) (n = 96) |
p-value |
Age, mean years (%) | 42.33 ± 14.30 | 44.03 ± 16.20 | 41.48 ± 13.31 | 0.260 |
Age group | ||||
≤ 20 | 7 (4.22) | 2 (4.3) | 5 (5.2) | 0.960 |
21–30 | 23 (16.08) | 7 (14.9) | 16 (16.7) | |
31–40 | 25 (17.48) | 9 (19.1) | 16 (16.7) | |
41–50 | 39 (27.27) | 12 (25.5) | 27 (28.1) | |
51–60 | 25 (17.48) | 10 (21.3) | 15 (15.6) | |
> 60 | 24 (16.78) | 7 (14.9) | 17 (17.7) | |
Sex | ||||
Male | 72 (50.35) | 22 (46.80) | 50 (52.08) | 0.553 |
Female | 71 (49.65) | 25 (53.20) | 46 (47.92) |
The most common endoscopic finding was erosive gastritis (53; 37.1%), followed by gastritis (48; 33.6 %), gastric ulcer (20; 14.0%), duodenal ulcer (11; 7.7%), and gastric carcinoma (five, 3.5%).
The prevalences of H. pylori in relation to different endoscopy diagnoses are shown in Table 3. The overall prevalence of H. pylori infection in gastritis was 15 (31.9%), in erosive gastritis 14 (29.8%), in gastric ulcer eight (17.0%), in duodenal ulcer seven (14.9%), in gastric carcinoma one (2.1%), and in normal gastric mucosa two (4.3%). Endoscopic findings such as gastritis, gastric ulcer, and duodenal ulcer were not significantly associated with H. pylori.
Table 3.
Prevalence of H. pylori in relation to endoscopic findings
Endoscopic finding |
H. pylori (+) (n = 47) |
H. pylori (−) (n = 96) |
All patients (n = 143) |
p-value |
---|---|---|---|---|
Gastritis, n (%) | 15 (31.9%) | 33 (34.4%) | 48 (33.6%) |
0.251 |
Erosive gastritis, n (%) | 14 (29.8%) | 39 (40.6%) | 53 (37.1%) | |
Gastric ulcer, n (%) | 8 (17.0%) | 12 (12.5%) | 20 (14.0%) | |
Duodenal ulcer, n (%) | 7 (14.9%) | 4 (4.2%) | 11 (7.7%) | |
Gastric carcinoma, n (%) | 1 (2.1) | 4 (4.2) | 5 (3.5%) | |
Normal, n (%) | 2 (4.3) | 4 (4.2) | 6 (4.2%) |
The rates of H. pylori infection for different gastroduodenal diseases detected by histopathology are shown in Table 4. Histologically, the highest rate of H. pylori infection was found among patients with duodenal ulcer (55.5%), followed by intestinal metaplasia (50%), gastric ulcer (39.8 %), gastric adenocarcinoma (33.3%), chronic gastritis (30.7%), and normal gastric mucosa (14.3%).
Table 4.
H. pylori infection status and gastroduodenal disease diagnosed by histopathological examination among the study population (n = 143)
Histopathological finding |
H. pylori-positive cases, n (%) | H. pylori-negative cases, n (%) | All patients, n = 143 (%) |
p-value |
Chronic gastritis | 31 (30.7) | 70 (69.3) | 101 (70.63) | 0.390 |
Chronic gastric ulcer | 7 (36.8) | 12 (63.2) | 19 (13.28) | 0.882 |
Duodenal ulcer | 5 (55.5) | 4 (44.5) | 9 (6.30) | 0.134 |
Intestinal metaplasia | 2 (50.0) | 2 (50.0) | 4 (2.80) | 0.459 |
Gastric carcinoma | 1 (33.3) | 2 (66.7) | 3 (2.09) | 0.986 |
Normal dyspeptic | 1 (14.3) | 6 (85.7) | 7 (4.90) | 0.283 |
The relationships between histopathology findings and endoscopic findings are shown in Table 5. Of the 101 endoscopically reported gastritis patients, 98 (97.1%) had gastritis and three (2.9%) had normal gastric mucosa. Of the 20 cases of gastric ulcer reported on endoscopy, 19 (95.0%) had chronic gastric ulcer and one (5.0%) had intestinal metaplasia. Of the 11 endoscopically reported duodenal ulcer patients, nine (81.8%) also had duodenal ulcer according to histopathological examination, one (9.1%) had gastritis and one (9.1%) had intestinal metaplasia. Of the five endoscopically reported gastric carcinoma patients, three (60.0%) showed gastric adenocarcinoma histologically and two (40.0%) exhibited intestinal metaplasia. Endoscopic findings were significantly correlated with histological findings (p < 0.001).
Table 5.
Relationship between endoscopic findings and histopathological findings among the study population (n = 143)
Endoscopic findings | Histopathological findings |
Total | |||||
---|---|---|---|---|---|---|---|
Gastritis, n (%) | Chronic gastric ulcer, n (%) | Duodenal ulcer, n (%) | Intestinal metaplasia, n (%) | Gastric carcinoma, n (%) | Normal, n (%) | ||
Gastritis | 98 (97.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 3 (2.9) | 101 (70.6) |
Gastric ulcer | 0 (0) | 19 (95.0) | 0 (0) | 1 (5.0) | 0 (0) | 0 (0) | 20 (13.9) |
Duodenal ulcer | 1 (9.1) | 0 (0) | 9 (81.8) | 1 (9.1) | 0 (0) | 0 (0) | 11 (7.6) |
Gastric carcinoma | 0 (0) | 0 (0) | 0 (0) | 2 (40.0) | 3 (60.0) | 0 (0) | 5 (3.5) |
Normal | 2 (33.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (66.7) | 6 (4.2) |
Total | 101 (70.6) |
19 (13.3) |
9 (6.3) |
4 (2.8) |
3 (2.1) |
7 (4.9) |
143 (100) |
Discussion
In total, 143 gastric biopsies were collected from dyspeptic patients who underwent endoscopy examination in the Department of Gastroenterology, BSMMU and Dhaka Medical College Hospital, Dhaka. For this study, H. pylori was detected by both phenotypic methods, such as rapid urease test and histological staining for H. pylori, and genotypic methods, such as ureC gene PCR. According to the definition of H. pylori-positive cases used in this study, only 47 (32.9%) were classified as H. pylori-positive and 96 (67.1%) as H. pylori-negative. This finding was in agreement with the findings of Niknam et al. (2014), who reported 31% H. pylori positivity among the adult dyspeptic population in Iran, and Aftab et al. (2018), who reported a 47% prevalence of H. pylori infection in adult dyspeptic patients in Bangladesh. In our study, only one gastric tissue biopsy was used in each test for determining H. pylori, although the organism is unevenly distributed throughout the gastric mucosa; this could have been a contributing factor to the comparatively lower prevalence of H. pylori detected. Moreover, the possible noncompliance of some participants with regard to not using proton pump inhibitors during the 4 weeks prior to endoscopic examination might have produced false-negative results with the rapid urease test and histopathology. Recently, several studies from Asian and Middle-Eastern countries have reported declining trends in H. pylori infection with improvements in hygiene conditions (Chen et al., 2007); Alazmi et al., 2010; Yim et al., 2007).
The study population ranged from 18 to over 65 years of age, with a mean age of 44.03 ± 16.20 years for H. pylori-positive cases. The prevalence of active H. pylori infection was highest in the 41–50 years age group (25.5%) and lowest (4.3%) in the < 20 years age group. Helaly et al. (2009) also found the highest percentage of H. pylori infection in the 41–50 years age group. The acquisition of H. pylori can occur at a young age as part of normal flora; however, in absence of treatment, infection can persist throughout the individual's lifetime and manifest later in life.
Higher prevalences of H. pylori have been found to be associated with lower socioeconomic groups, as well as with large families, poor hygiene, low standards of living, and overcrowded conditions (Rastogi et al., 2016). Studies have also suggested that older age groups have been more exposed to other etiological factors, such as NSAIDs, smoking, and stress, which are all potential contributing factors to a higher prevalence of H. pylori (Mabeku et al., 2018).
Among the 143 dyspeptic cases in our study, 71 (49.7%) were female and 72 (50.3%) were male, giving an almost equal male:female ratio. The prevalence of H. pylori infection was slightly higher in the female population (53.20%) compared with males (46.80%), although this difference was not significant. This finding was similar to that in a study by Singh et al. (2002), which did not find any significant association between H. pylori infection and sex distribution. However, another study found males to have a greater prevalence of H. pylori infection (Ibrahim et al. (2017).
Among the 143 cases in our study, the majority of patients were endoscopically reported as having erosive gastritis (37.1%), followed by gastritis (33.6%), gastric ulcer (14.0%), duodenal ulcer (7.7%), and gastric carcinoma (3.5%); these figures were similar to those found in another study conducted in Dhaka (Kismat et al., 2019). In our study, gastritis was the most common endoscopic abnormality among the study population, and also among those who were found to be infected with H. pylori. However, there was no statistically significant association between gastritis and H. pylori infection.
The most common histopathological finding was chronic gastritis (70.63%), followed by gastric ulcer (13.28%), duodenal ulcer (6.30%), intestinal metaplasia (2.80%), gastric carcinoma (2.09%), with 4.90% found to have normal gastric mucosa.
In this study, 55.5% of the duodenal ulcer patients and 30.7% of the chronic gastritis patients were infected with H. pylori. These findings were in agreement with those of Helaly et al. (2009), who found 54.5% of duodenal ulcer patients and 41.1% of gastritis patients to have H. pylori in Egypt. In our study, among the 47 H. pylori-positive cases, 50% had intestinal metaplasia according to histopathology, which was similar to the finding of Lee et al. (2007).
Among the 101 endoscopically reported gastritis patients, 97.1% had gastritis, and 2.9% had normal mucosa. Of the six endoscopically diagnosed normal cases, 33.3% were diagnosed with gastritis of various grades, and 66.6% had normal mucosa. Out of 20 endoscopically diagnosed gastric ulcer cases, 19 (95.0%) were diagnosed as chronic gastric ulcer and one (5.0%) as intestinal metaplasia in histopathology. 81.8% of the duodenal ulcer cases in endoscopy were diagnosed as duodenal ulcer in histology. Out of six gastric carcinoma cases in endoscopy, three (60.0%) were diagnosed as adenocarcinoma and two (40.0%) as intestinal metaplasia in histology. Endoscopic findings were significantly correlated with histological findings (p < 0.001).
Clinicians should test and treat H. pylori infection if resources are available. In resource-poor settings, where the confirmatory test is not available or may not be cost effective, empirical therapy is recommended.
Conclusion
H. pylori infection is one of the major causes of dyspeptic symptoms in the Bangladeshi population. Although its prevalence is declining, it is still a public health burden in a developing country like Bangladesh because it causes considerable individual suffering and, consequently, loss of manpower. Proper evaluation and eradication therapy are needed to overcome this situation. Since significant correlations between endoscopy and histopathology findings have been observed, endoscopic examination can be used as an alternative for gastric disease detection where histopathology is not available. However, normal endoscopic appearance is a poor predictor of histological findings. H. pylori infection may be positively associated with duodenal ulcer and intestinal metaplasia in a statistically significant manner.
Acknowledgments
Acknowledgments
The authors are very grateful to all the faculty members of the Department of Microbiology, BSMMU. They would also like to thank all those patients who participated in the study.
Conflicts of Interest
The authors declare no conflicts of interest regarding the publication of this paper.
Funding Source
Bangladesh Medical Research Council (BMRC)
Ethical Approval Statement
Ethical clearance was granted by the Institutional Review Board (IRB), BSMMU.
Contributor Information
Nusrat Noor Tanni, Email: nusratnoortanni@gmail.com.
Sharmeen Ahmed, Email: drsharmeenahmed@gmail.com.
Shaheda Anwar, Email: shahedaanwar17@gmail.com.
Saifa Kismat, Email: shifasaifakismat@gmail.com.
Kakali Halder, Email: dr.kakali7@gmail.com.
Maherun Nesa, Email: munbsmmu@gmail.com.
Farjana Binte Habib, Email: farjanahabib33@gmail.com.
References
- Aftab H, Yamaoka Y, Ahmed F, Khan AA, Subsomwong P, Miftahussurur M, et al. Validation of diagnostic tests and epidemiology of Helicobacter pylori infection in Bangladesh. The Journal of Infection in Developing Countries. 2018;12:305–312. doi: 10.3855/jidc.9841. [DOI] [PubMed] [Google Scholar]
- Alazmi WM, Siddique I, Alateeqi N, Al-Nakib B. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterology. 2010;10(1):1–4. doi: 10.1186/1471-230X-10-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aminde JA, Dedino GA, Ngwasiri CA, Ombaku KS, Makon CA, Aminde LN. Helicobacter pylori infection among patients presenting with dyspepsia at a primary care setting in Cameroon: seroprevalence, five-year trend and predictors. BMC infectious diseases. 2019;19(1):1–9. doi: 10.1186/s12879-019-3677-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen J, Bu XL, Wang QY, Hu PJ, Chen MH. Decreasing seroprevalence of Helicobacter pylori infection during 1993–2003 in Guangzhou, southern China. Helicobacter. 2007;12:164–169. doi: 10.1111/j.1523-5378.2007.00487.x. [DOI] [PubMed] [Google Scholar]
- Conroy RT, Siddiqi B. Dyspepsia. Primary Care: Clinics in Office Practice. 2007;34(1):99–108. doi: 10.1016/j.pop.2007.02.001. [DOI] [PubMed] [Google Scholar]
- Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia–Pacific consensus guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology. 2009;24:1587–1600. doi: 10.1111/j.1440-1746.2009.05982.x. [DOI] [PubMed] [Google Scholar]
- Ghoshal UC, Singh R, Chang FY, Hou X, Wong BC, Kachintorn U. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. Journal of Neurogastroenterology and Motility. 2011;17(3):235. doi: 10.5056/jnm.2011.17.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Helaly GF, El-Afandy NM, Hassan AA, Dowidar NL, Sharaf SM. Diagnostic value of housekeeping [glmM] gene expression in antral biopsies in comparison to rapid urease test and histological detection of Helicobacter Pylori infection. Egypt J Med Microbiology. 2009;18:119–130. [Google Scholar]
- Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Digestive and Liver Disease. 2017;49(7):742–749. doi: 10.1016/j.dld.2017.03.019. [DOI] [PubMed] [Google Scholar]
- Kismat S, Tanni NN, Akhtar R, Roy CK, Rahman MM, Anwar S, et al. Correlation between endoscopic and histological findings of dyspeptic patients and their association with Helicobacter pylori infection. Bangladesh Journal of Medical Microbiology. 2019;13(2):11–17. doi: 10.3329/bjmm.v13i2.51788. [DOI] [Google Scholar]
- Krogfelt KA, Lehours P, Mégraud F. Diagnosis of Helicobacter pylori infection. Helicobacter. 2005;10:5–13. doi: 10.1111/j.1523-5378.2005.00341.x. [DOI] [PubMed] [Google Scholar]
- Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews. 2006;19:449–490. doi: 10.1128/CMR.00054-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee Y, Jeon YC, Koo TY, Cho HS, Byun TJ, Kim TY, et al. Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication. The Korean Journal of Gastroenterology — Taehan Sohwagi Hakhoe chi. 2007;50(5):299–305. doi: 10.4166/kjg.2010.56.5.299. [DOI] [PubMed] [Google Scholar]
- Lu JJ, Perng CL, Shyu RY, Chen CH, Lou Q, Chong SK, Lee CH. Comparison of five PCR methods for detection of Helicobacter pylori DNA in gastric tissues. Journal of Clinical Microbiology. 1999;37(3):772–774. doi: 10.1128/JCM.37.3.772-774.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mabeku LB, Ngamga ML, Leundji H. Potential risk factors and prevalence of Helicobacter pylori infection among adult patients with dyspepsia symptoms in Cameroon. BMC Infectious Diseases. 2018;18(1):278. doi: 10.1186/s12879-018-3146-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mapel D, Roberts M, Overhiser A, Mason A. The epidemiology, diagnosis, and cost of dyspepsia and Helicobater pylori gastritis: a case–control analysis in the southwestern United States. Helicobacter. 2013;18:54–65. doi: 10.1111/j.1523-5378.2012.00988.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical Microbiology Reviews. 2007;20:280–322. doi: 10.1128/CMR.00033-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishra S, Singh V, Rao G, Jain AK, Dixit VK, Gulati AK, et al. Detection of Helicobacter pylori in stool specimens: comparative evaluation of nested PCR and antigen detection. The Journal of Infection in Developing Countries. 2008;2:206–210. doi: 10.3855/jidc.264. [DOI] [PubMed] [Google Scholar]
- Nguyen VX, Le Nguyen VT, Nguyen CC. Appropriate use of endoscopy in the diagnosis and treatment of gastrointestinal diseases: up-to-date indications for primary care providers. International Journal of General Medicine. 2010;3:345. doi: 10.2147/IJGM.S14555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niknam R, Seddigh M, Fattahi MR, Dehghanian A, Mahmoudi L. Prevalence of Helicobacter pylori in patients with dyspepsia. Jundishapur Journal of Microbiology. 2014;7(10) doi: 10.5812/jjm.12676. https://doi: 10.5812/jjm.12676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rastogi M, Rastogi D, Singh S, Agarwal A, Priyadarshi B, Middha T. Prevalence of Helicobacter pylori in asymptomatic adult patients in a tertiary care hospital: a cross sectional study. Biomed Res. 2016;26(1):117. https://doi:10.5958/2320-608X. 2016.00058. 5. [Google Scholar]
- Saha R, Ahmed S, Sattar H, Begum M, Uddin BM, Saleh AA, et al. Association of H. pylori cagA gene with duodenal ulcer and gastric carcinoma in Bangladeshi patients. American Journal of Microbiological Research. 2018;6(2):57–62. doi: 10.12691/ajmr-6-2-4. [DOI] [Google Scholar]
- Selgrad M, Malfertheiner P. Management of Helicobacter pylori infection: what should the surgeon know? Visceral Medicine 2017;33(3):216–9. https://doi.org/10.1159/000477977 [DOI] [PMC free article] [PubMed]
- Singh V, Trikha B, Nain CK, Singh K, Vaiphei K. Epidemiology of Helicobacter pylori and peptic ulcer in India. Journal of Gastroenterology and Hepatology. 2002;17(6):659–665. doi: 10.1046/j.1440-1746.2002.02746.x. [DOI] [PubMed] [Google Scholar]
- Smith SM, O'Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World Journal of Gastroenterology. 2014;20(29):9912. doi: 10.3748/wjg.v20.i29.9912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Srinivas Y, Prasad PK, Sai ND. Prevalence and impact of Helicobacter pylori in dyspepsia. International Surgery Journal. 2016;3:305–309. doi: 10.18203/2349-2902.isj20160248. [DOI] [Google Scholar]
- Tongtawee T, Dechsukhum C, Leeanansaksiri W, Kaewpitoon S, Kaewpitoon N, Loyd RA, et al. Improved detection of Helicobacter pylori infection and premalignant gastric mucosa using ‘site specific biopsy’: a randomized control clinical trial. Asian Pacific Journal of Cancer Prevention. 2016;16:8487–8490. doi: 10.7314/APJCP.2015.16.18.8487. [DOI] [PubMed] [Google Scholar]
- Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12:333–340. doi: 10.1111/j.1523-5378.2007.00504.x. [DOI] [PubMed] [Google Scholar]